Medtronic

The Fridley-based company makes cardiovascular, cardiac rhythm, neurological, spinal, diabetes and surgical medical device technologies and therapies.

74.08 USD  +0.31 (+0.42%)
Delayed Price  /  Updated: 4:30 PM CST, Dec 24, 2014  /  Add to My Watchlist      
52 Week High 75.66
52 Week Low 53.33
Volume 3237695
Bid (Size) 100
Ask (Size) 1000
Today's Range 74.45 - 73.42
Shares Outstanding 984316549
Dividend Yield 1.195

key info

Follow Medtronic

Connect with facebook Connect with Linkedin

Related Companies

StarTribune 100

A measure of the largest publicly held companies with headquarters in Minnesota ranked by revenue.

star tribune coverage

Medtronic scores a win in executive payments case

ARTICLE Updated: Dec 24 2014 - 10:14 PM

A federal judge will not block $63 million in payments to Medtronic executives tied to the Fridley-based devicemaker’s plans to move legal headquarters to Ireland.But the company’s...

Medtronic, St. Jude roll out enhanced devices to restore normal heart rhythms

ARTICLE Updated: Dec 22 2014 - 10:13 AM

When shocking an out-of-sync heart, having more points of electrical contact between a device and the patient gives doctors better options to force a failing cardiac muscle to beat in rhythm...

China, South Korea approve Medtronic-Covidien deal

ARTICLE Updated: Dec 4 2014 - 9:09 PM

Chinese and South Korean antitrust officials have signed off on Medtronic’s $42.9 billion acquisition of Dublin-based health care supplier Covidien, providing the last of a dozen government...

Computer hackers taking aim at insider information at health care companies

ARTICLE Updated: Dec 1 2014 - 9:27 PM

A surgically precise e-mail hacking effort is targeting health care companies in an effort to steal corporate secrets for insider stock trading.While the hacking techniques are relatively common,...

In unusual move, devicemaker crowdfunds its high blood pressure therapy

ARTICLE Updated: Nov 29 2014 - 2:00 PM

About 50 million Americans pop a pill to control high blood pressure, and medical device companies are vying to design a high-tech drug-free alternative for hypertension.All three of Minnesota’s big...

See all content

executive compensation

Omar Ishrak

Chm., CEO

Current year rank 13
Current year compensation $8,331,159
Percent change of the CEO 33.0

See more state CEO pay packages

executive team

  • Omar Ishrak, Chairman and CEO
  • Gary Ellis, Senior Vice President and CFO
  • Cameron Findlay, Senior Vice President and General Counsel
  • Michael Coyle, Executive Vice President and Group President, Cardiac and Vascular

twitter feed

minnesota topics minnesota topics

Minnesota Topics are a comprehensive collection of Star Tribune content on select people, places and companies.

ADVERTISEMENT

ADVERTISEMENT

 
Close